Search

Epilepsy is one of the five major neuropsychiatric diseases that the World Health Organization (WHO) focuses on prevention and treatment. From June 2017 to the present, the Epilepsy Working Group of National Center for Healthcare Quality Management in Neurological Diseases has launched the national epilepsy medical quality indicator system after three batches of pilots, based on full reference to domestic and overseas evidence-based evidence and previous indicator experience. It has built a medical quality control system for epilepsy and convulsive status epilepticus covering 130 sentinel hospitals in 31 provincial administrative regions across China. Regarding on the diagnosis and treatment indicator data feedback from sentinel hospitals, the system was revised based on the published quality control indicators. Twenty validated indicators in epilepsy and convulsive status epilepticus were included. In 2020, the General Office of the National Health Commission issued the indicator system. Disease quality control indicators rely on the national quality control network system to implement medical quality control and management, aiming at improving medical quality and promoting the homogenization of diagnosis and treatment. Currently, this indicator system has been incorporated into the accreditation standards for tertiary hospitals. In addition to strengthening the training, analysis and feedback of information on the indicators, the standardized diagnosis and treatment of epilepsy and convulsive status epilepticus in medical institutions at all levels are constantly promoted. [ABSTRACT FROM AUTHOR]

Epilepsy is one of the five major neuropsychiatric diseases that the World Health Organization focuses on. There are more than 10 million people with epilepsy in China, which lead to tremendous burden of disease. Fortunately, over 70% of epilepsy patients can achieve the treatment goal of seizure control and reintegration into society under standardized treatment. Improving the qualityof diagnosis and treatment of epilepsy can effectively improve the accessibility of medical care in people with epilepsy in China. In 2017, with the support of the National Health Commission, the National Center for Healthcare Quality Management in Neurological Diseases set up the Epilepsy Medical Working Group to start the construction of the medical quality control system in epilepsy and convulsive status epilepticus. The construction of medical quality control system for epilepsy and convulsive status epilepticus strengthened the national epilepsy management system, found out the status of diagnosis and treatment in China, built a dynamic feedback mechanism for the medical quality system with multiple data sources complementing each other. Applying medical quality tools for epilepsy and convulsive status epilepticus, which have continued to promote the homogenization of epilepsy diagnosis and treatment in China. [ABSTRACT FROM AUTHOR]